Ph.D. Paul A. Wagner - 20 Nov 2023 Form 4 Insider Report for Forte Biosciences, Inc. (FBRX)

Role
CEO, Secretary and Chair of the Board, Director
Signature
/s/ Paul A. Wagner, Ph.D.
Issuer symbol
FBRX
Transactions as of
20 Nov 2023
Net transactions value
+$3,220
Form type
4
Filing time
22 Nov 2023, 17:51:29 UTC
Previous filing
03 Oct 2023
Next filing
08 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FBRX Common Stock Purchase $2,332 +5,300 +0.31% $0.4400 1,709,671 20 Nov 2023 Direct
transaction FBRX Common Stock Purchase $673 +1,566 +0.09% $0.4300 1,711,237 20 Nov 2023 Direct
transaction FBRX Common Stock Purchase $42.51 +100 +0.01% $0.4251 1,711,337 20 Nov 2023 Direct
transaction FBRX Common Stock Purchase $172 +400 +0.02% $0.4300 1,711,737 22 Nov 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

CEO, Secretary and Chair of the Board